Roche (SWX:ROP) Wins Key Cancer Drug And Diagnostic FDA Milestones
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Roche…
Roche (SWX:ROP) Wins Key Cancer Drug And Diagnostic FDA Milestones
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Roche…
FDA Approves Roche PTEN Assay for Prostate Cancer Protein Deficiency
Roche announced that the Food and Drug Administration (FDA) approved the Ventana PTEN (SP218) RxDx Assay, an immunohistochemistry…
Roche VENTANA MMR RxDx Panel Gains EU IVDR Approval for Multiple Cancers
Roche has received European Union In Vitro Diagnostic Regulation approval for several label expansions of its VENTANA MMR…
Roche to Acquire PathAI to Expand Digital Pathology and AI Diagnostics
Roche has entered into a definitive merger agreement to acquire PathAI, a US-based company specializing in digital pathology…
Roche to acquire Pathai for up to $1.05B
Roche Holding AG has agreed to acquire Pathai Inc. for up to $1.05 billion in a bid to…
Roche to Acquire PathAI for $750M Upfront
Roche (OTCQX: RHHBY) agreed to acquire PathAI to expand its digital pathology and…
Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG)
In recent developments, Roche has featured prominently in the race to develop TIGIT inhibitors for cancer immunotherapy, while…
Roche Gains CE IVDR Approval for Expanded HER2 Companion Diagnostic
Roche has received CE IVDR approval for two label expansions of its VENTANA HER2 (4B5) Rabbit Monoclonal Primary…
Roche Gains FDA Approval for Expanded HER2 Diagnostic Test Indications
The US Food and Drug Administration (FDA) has approved expanded indications for Roche’s Pathway anti-HER2/neu (4B5) Rabbit Monoclonal…
Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
Summary:The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic to identify MET protein…